Ozempic Lawsuit

Is There an Ozempic and Wegovy Lawsuit?

Yes, lawsuit for Ozempic, Wegovy, Rybelsus and Mounjaro users are now being investigated by lawyers. The lawsuits allege that the manufacturers placed their desire for profits before consumer safety, failing to warn doctors and users that these weight loss drugs can cause severe gastrointestinal side effects, particularly stomach paralysis or gastroparesis, which is a disorder that slows food movement from the stomach to the intestine.

Who is Eligible for an Ozempic Lawsuit?

Financial compensation may be available through an Ozempic lawsuit or Wegovy lawsuit for individuals who received any number of Ozempic, Wegovy or Mounjaro injections, or took Rybelsus tablets, and suffered any of the following complications:

• Gastroparesis (delayed gastric emptying)
• Gallbladder disease
• Gallbladder removal
• Gallstones
• Severe vomiting
• Severe diarrhea

To determine if you or a loved one may have a case, submit information for review by an Ozempic lawyer, who will help evaluate the circumstances and determine if you have an Ozempic claim. Attorneys handle all Ozempic Wegovy lawsuits on a contingency fee basis, which means that there are no fees or expenses paid unless a settlement or lawsuit payout is received.

Latest 2023 Ozempic Lawsuit Updates

August 2023 Update: The first Ozempic and Mounjaro lawsuit was filed over gastroparesis side effects in the U.S. District Court for the District of Louisiana.

July 2023 Update: An investigative report published by CNN highlighted the growing number of individuals suffering stomach paralysis from Ozempic and Wegovy, and outlined the growing evidence that the diet drug makers were aware of the potential risk.

June 2023 Update: As a result of the risk of nausea and vomiting from Ozempic and Wegovy, the American Society of Anesthesiologists (ASA) issued a warning that users should pause the diet drugs before elective surgery, due to the risk of suffocation during anesthesia treatments.

Ozempic Lawsuit Overview

Ozempic, also known as semaglutide, is a prescription medication developed by Novo Nordisk, which was approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes on December 5, 2017. Ozempic is an injectable glucagon-like peptide-1 (GLP-1) receptor agonist, which belongs to a class of drugs that help to lower blood sugar levels in the body by increasing insulin secretion.

Novo Nordisk subsequently released an oral version of semaglutide in a tablet for the treatment of Type 2 diabetes named Rybelsus, which was approved by the FDA in 2019.

While Ozempic and Rybelsus were specifically designed to treat people with type 2 diabetes, the drugs quickly became widely used off-label for the perceived benefits of helping some individuals lose weight. With Novo Nordisk pumping hundreds of millions of dollars into advertising and celebrity endorsers speaking out on the weight loss benefits, the popularity of Ozempic for weight loss purposes skyrocketed, and substantially increased profits for the drug maker.

As a result, Novo Nordisk quickly developed a third form of semaglutide marketed under the brand name Wegovy, which was approved by the FDA in June 2021, specifically for use as a weight loss drug by adults with obesity and those overweight with certain health conditions.

With more individuals taking semaglutide for weight loss, widespread reports quickly began to emerge about severe and debilitating side effects from Ozempic, Wegovy and Rybelsus, including severe gastrointestinal disorders. However, there is now growing evidence that Novo Nordisk knew or should have known about the risk of long-term Ozempic stomach problems, yet failed to adequately disclose

Gastroparesis lawsuits are now being pursued against Novo Nordisk for failing to adequately research the diet drug or warn about the risk of severe and long-lasting Ozempic side effects.

Who is the Ozempic Lawsuit Against?

The Ozempic lawsuit is against Novo Nordisk and its subsidiaries, which manufactured the weight loss and diabetes drugs Ozempic, Wegovy and Rybelsus.

There is also a Mounjaro lawsuit against Eli Lilly for its drug tirzepratide, a competing diabetes and weight loss drug. Both pharmaceutical companies Novo Nordisk and Eli Lilly failed to warn about the diabetes drugs side effects, according to complaints filed by former users.

Lawsuits are not being filed against individual health care professionals who prescribed Ozempic, Wegovy Mounjaro or Rybelsus, because the manufacturer failed to warn doctors and patients about the serious side effects of the diabetes medications and weight loss drugs.

Is there an Ozempic Class Action Lawsuit?

No. At this time, semaglutide lawsuits are being pursued as individual claims on behalf of individuals who have suffered personal injuries and gastrointestinal problems from Ozempic, Wegovy and/or Rybelsus.

It is possible future Ozempic class action lawsuits may be filed to seek medical monitoring for users who may face future risks after using the diet drugs, or to seek refunds from the drug makers for failing to adequately disclose the serious risks associated with the medication. However, gastroparesis lawsuits will involve unique damages for each individual plaintiff, and will not be litigated through a class action lawsuit for Ozempic, Wegovy or Rybelsus users.

With approximately 15% of Americans having used Ozempic for weight loss at some point, it widely expected that tens of thousands of Ozempic injury claims will be pursued by individuals throughout the federal court system in the coming months and years.

Since each claim will involve similar questions of fact and law, a federal multidistrict litigation (MDL) may be established in the future, where discovery and pretrial proceedings will be managed similar to an Ozempic class action. However, ultimately, if the drug makers fail to reach Ozempic settlements or another resolution for the litigation in any MDL that is established, each individual claim may later be remanded back to the U.S. District Court where it was filed for a separate trial in the future.

Ozempic Gastrointestinal Side Effects

Ozempic lawsuits and Mounjaro lawsuits are being pursued for individuals throughout the United States, pointing to a growing body of medical research that has established a link between Ozempic and Mounjaro and gastrointestinal side effects that may cause several painful and debilitating injuries.

Studies Linking Ozempic To Stomach Problems

Since the launch of Ozempic and its subsequent forms, clinical trials and a series of medical studies have been published that have drawn a link between Ozempic and gastrointestinal problems.

Ozempic Clinical Trials Show Symptoms of Stomach Paralysis

Lawsuits allege the drug maker was aware of the risk of stomach paralysis injuries during clinical trials, yet failed to further investigate the risks or disclose it as a possible side effect.

During semaglutide clinical trials, close to 44% of Wegovy users experienced nausea and nearly a quarter of the test subjects also reported incidents of vomiting, which are both symptoms prevalent in cases of gastroparesis.

Similar results were seen in the clinical trials for Ozempic, which is essentially Wegovy administered at a lesser dosage. During Ozempic clinical trials, one out of every five participants reported feelings of nausea, while vomiting was observed in one out of every ten individuals.

Ozempic Gallbladder Disease Study

In 2017, a groundbreaking meta-analysis focusing on Ozempic’s impact on pancreatitis and gallbladder disease was published in the journal Diabetes, Obesity & Metabolism. This particular study marked the first occasion that Ozempic was identified as being correlated with a heightened risk of gallbladder disease.

Specifically, researchers found individuals with Type 2 diabetes being treated with Ozempic and other GLP-1 receptor agonists were at a significant risk of developing gallbladder deficiencies and failure.

Ozempic Vomiting, Nausea Risks During Surgery

In July 2023, the American Society of Anesthesiologists (ASA) issued a press release highlighting the risk that delayed stomach emptying on Ozempic and Wegovy may have during surgery. As a result of Ozempic vomiting and nausea, users may face an increased risk of suffocation and aspiration of food into the airways and lungs during general anesthesia and deep sedation.

The Wegovy and Ozempic warning was part of new ASA guidance issued in response to the much wider use of the diet drugs, which recommends patients taking drugs like Ozempic or Wegovy on a daily basis, should not take it the day of the procedure. If they take the drug on a weekly basis, they should pause taking the medications a week before their surgery. In addition, they should consider consulting with an endocrinologist while off the drugs to help control their diabetes.

To reduce the risk of surgical complications on Ozempic, the guidance also calls for doctors to consider delaying a procedure if the patient is experiencing gastrointestinal symptoms, such as severe nausea, vomiting, abdominal bloating or abdominal pain the day of the procedure.

Is There an Ozempic Recall?

No. Despite the growing number of adverse events linked to Ozempic, Wegovy and Rybelsus, the manufacturer has yet to issue a formal recall or update patient safety information.

Ozempic Lawsuit Examples

Ozempic Stomach Paralysis Lawsuit: Jacklyn Bjorklund filed an Ozempic lawsuit in the U.S. District Court for the Western District of Louisiana, indicating that she used Ozempic or more than a year and suffers from severe gastroparesis, including vomiting, stomach pain, gastrointestinal burning and repeated hospital emergency room visits for stomach issues.

Bjorklund claims that as a result of excessive vomiting caused by Ozempic, she indicates that some of her teeth fell out and she has been prescribed additional medication to prevent throwing up food hours after eating.

Bjorklund’s complaint indicates that her stomach injuries were the direct result of side effects of Ozempic and Mounjaro, alleging the manufacturers knew, or should have known, that the drugs increase the risk of gastroparesis and gastroenteritis.

Ozempic Lawyers Reviewing Cases Nationwide

If you or a loved one developed stomach injuries after taking Ozempic, Wegovy, Rybelsus, Mounjaro or other GLP-1 agonists, submit information about your potential claim for review by a product liability lawyer to determine whether a weight loss drug lawsuit settlement may be available.

Ozempic injury lawyers provide free claim evaluations and consultations. There are no fees or expenses unless a recovery is obtained in your case.